Based on the results derived from GEPIA, the expression of G6PC3, IGFBP2, and TIMP4 were significantly up-regulated in GBM, while the expression of PTPRN and RGS14 were significantly down-regulated (Figure 6). Here, RGS14 is linked to glioblastoma.